COMMUNIQUÉS West-GlobeNewswire

-
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
30/09/2024 -
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
30/09/2024 -
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
30/09/2024 -
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
28/09/2024 -
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
28/09/2024 -
Montréal accueille le 4e Symposium international sur l’arthrogrypose congénitale multiple (ACM)
28/09/2024 -
Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)
28/09/2024 -
SOGC Calls for Vigilance and Continued Advocacy on International Safe Abortion Day
28/09/2024 -
La SOGC lance un appel à la vigilance et à la poursuite des représentations pour protéger les droits des femmes à l'occasion de la Journée internationale de l'avortement sécuritaire
28/09/2024 -
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
28/09/2024 -
BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular-related Hospitalization Events
28/09/2024 -
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
27/09/2024 -
CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
27/09/2024 -
CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
27/09/2024 -
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
27/09/2024 -
Les Données de l'Étude Pivot DREAM Présentées lors de l'International Surgical Sleep Society 2024 Educational Update
27/09/2024 -
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27/09/2024 -
PacBio Grants Equity Incentive Award to New Employee
27/09/2024 -
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
27/09/2024
Pages